Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6887257 | 0.93 | GSK3B (0.33) | GSK3BTSHR | |
| SCHEMBL6886842 | 0.92 | HDAC1 (0.35) | GSK3B | |
| SCHEMBL6885213 | 0.90 | GSK3B (0.32) | GSK3B | |
| SCHEMBL6885088 | 0.85 | GSK3B (0.36) | GSK3BTSHR | |
| SCHEMBL6884989 | 0.85 | GSK3B (0.36) | GSK3BTSHR | |
| SCHEMBL6885503 | 0.84 | GSK3B (0.43) | GSK3BTSHR | |
| SCHEMBL6884015 | 0.84 | GSK3B (0.35) | GSK3BTSHR | |
| SCHEMBL6887384 | 0.84 | GSK3B (0.36) | GSK3BTSHR | |
| SCHEMBL6885551 | 0.84 | GSK3B (0.36) | GSK3BTSHR | |
| SCHEMBL6886429 | 0.82 | GSK3B (0.33) | GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1411954-A2 | MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION | Pharmasset Limited (BB) | 2004-04-28 | — | — | EP | disclosed |
| WO-2002032920-A2 | MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION | PHARMASSET LIMITED (BB) | 2002-04-25 | — | — | WO | disclosed |